3 Stories We Are Following Today 4-10-25
In this episode, Scott Becker discusses the impact of a temporary pause in tariffs, a dip in the Consumer Price Index, and shifting treasury yields.
Make America Healthy Again + 5 More Concepts 4-10-25
In this episode, Scott Becker discusses the concept of “Make America Healthy Again” (MAHA), Medicare Advantage, tariffs, market uncertainty, and political reactions.
Healthcare Private Equity Update with Holly Buckley of McGuireWoods LLP 4-9-25
In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, joins Scott Becker to discuss deal market trends, regulatory headwinds, and investor sentiment in healthcare.
Twitter Poll: Will You Cut Personal or Business Spending Due to Recent Market Downturns? 4-9-25
In this episode, Scott shares results from a poll he conducted on Twitter.
14 Short Notes for Today 4-9-25
In this episode, Scott Becker shares 14 quick takes on current market trends, investor sentiment, trade tensions, and economic outlooks.
3 Ways of Judging a Leader 3-9-25
In this episode, Scott Becker share three measures of strong leadership: delivering results, developing other leaders, and leaving a lasting legacy that thrives beyond their tenure.
It’s All Okay 4-9-25
In this episode, Scott Becker shares insights on how mindset and context help us navigate challenges and why maintaining perspective is key.
The Markets, Warren Buffett’s Core Thought on Doing Deals, & My Putting 4-8-25
In this episode, Scott Becker shares a quick market update, reflects on Warren Buffett’s timeless deal-making advice, and admits to his putting woes on the golf course.
Harvard, Higher Education & the Addiction to Federal Funding 4-8-25
In this episode, Scott Becker discusses Harvard’s potential $9 billion loss in federal funding, questioning how elite universities became so reliant on government money despite massive endowments
Health Insurance, Cannabis, & Apple 4-8-25
In this episode, Scott Becker breaks down three key stories: a Medicare Advantage rate hike lifting health insurers, ongoing struggles in the cannabis market, and Apple’s recent stock decline